Adelaide Research & Scholarship: Search

Search

Results 1-10 of 65 (Search time: 0.003 seconds).

previous
1
2
3
4
...
7
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2017	DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironment	Hewett, D.; Vandyke, K.; Lawrence, D.; Friend, N.; Noll, J.; Geoghegan, J.; Croucher, P.; Zannettino, A.
	2006	Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant	Butler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
	2007	Role of p53 in irinotecan-induced intestinal cell death and mucosal damage	Bowen, J.; Gibson, R.; Stringer, A.; Chan, T.; Prabowo, A.; Cummins, A.; Keefe, D.
	2020	Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo	Zeissig, M.N.; Hewett, D.R.; Panagopoulos, V.; Mrozik, K.M.; To, L.B.; Croucher, P.I.; Zannettino, A.C.W.; Vandyke, K.
	2019	APOMAB antibody-drug conjugates targeting dead tumor cells are effective in vivo	Staudacher, A.H.; Li, Y.; Liapis, V.; Hou, J.J.C.; Chin, D.; Dolezal, O.; Adams, T.E.; van Berkel, P.H.; Brown, M.P.
	2019	OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL	Evans, K.; Duan, J.X.; Pritchard, T.; Jones, C.D.; McDermott, L.; Gu, Z.; Toscan, C.E.; El-Zein, N.; Mayoh, C.; Erickson, S.W.; Guo, Y.; Meng, F.; Jung, D.; Rathi, K.S.; Roberts, K.G.; Mullighan, C.G.; Shia, C.S.; Pearce, T.; Teicher, B.A.; Smith, M.A.; et al.
	2017	Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer	Ponnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
	2020	The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1	Carmichael, C.L.; Wang, J.; Nguyen, T.; Kolawole, O.; Benyoucef, A.; De Mazière, C.; Milne, A.R.; Samuel, S.; Gillinder, K.; Hediyeh-Zadeh, S.; Vo, A.N.Q.; Huang, Y.; Knezevic, K.; McInnes, W.R.L.; Shields, B.J.; Mitchell, H.; Ritchie, M.E.; Lammens, T.; Lintermans, B.; Van Vlierberghe, P.; et al.
	2019	Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma	Neubauer, H.A.; Tea, M.N.; Zebol, J.R.; Gliddon, B.L.; Stefanidis, C.; Moretti, P.A.B.; Pitman, M.R.; Costabile, M.; Kular, J.; Stringer, B.W.; Day, B.W.; Samuel, M.S.; Bonder, C.S.; Powell, J.A.; Pitson, S.M.
	2020	Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion	Kohno, S.; Linn, P.; Nagatani, N.; Watanabe, Y.; Kumar, S.; Soga, T.; Takahashi, C.